TABLE 3.
Prevalence of genotypes
| Genotypea | Prevalenceb (%) |
|---|---|
| Thalassemia patients | |
| 1 | 61.2 |
| 2 | 18.8 |
| 3 | 6.2 |
| 11 | 56.3 |
| 12 | 9.3 |
| 13 | 3.1 |
| 18 | 3.1 |
| 22 | 3.1 |
| 23 | 3.1 |
| JT33F | 3.1 |
| JT34F | 3.1 |
| CT39F | 6.2 |
| CT44F | 6.2 |
| SENV-A | 9.4 |
| SENV-B | 3.1 |
| SENV-H | 22.2 |
| TLMV | 31.3 |
| Healthy individuals (controls) | |
| 1 | 25.0 |
| 2 | 12.5 |
| 3 | 12.5 |
| 11 | 75.0 |
| CT39F | 25.0 |
| CT44F | 12.5 |
| SENV-D | 12.5 |
| SENV-H | 62.5 |
a
Recently classified genotypes of TTV, discovered by Peng et al. (30), in this study are indicated in boldface.
b
Prevalences of various genotypes of TTV and TLMVs are indicated by the frequencies of their appearance in the PCR product clones derived from 32 thalassemia patients and 8 healthy individuals.